6,729
Views
90
CrossRef citations to date
0
Altmetric
Review

Targeting the cell cycle in breast cancer: towards the next phase

, , & ORCID Icon
Pages 1871-1885 | Received 02 May 2018, Accepted 07 Jul 2018, Published online: 11 Sep 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Gujie Wu, Yipeng Dong, Qin Hu, Huiyun Ma, Qun Xu, Kun Xu, Hongyu Chen, Zheng Yang & Min He. (2023) HGH1 and the immune landscape: a novel prognostic marker for immune-desert tumor microenvironment identification and immunotherapy outcome prediction in human cancers. Cell Cycle 22:18, pages 1969-1985.
Read now
Ying Zhao, Haokun Liu, Mingzhen Fan, Yuyang Miao, Xiaoe Zhao, Qiang Wei & Baohua Ma. (2022) G protein-coupled receptor 30 mediates cell proliferation of goat mammary epithelial cells via MEK/ERK&PI3K/AKT signaling pathway. Cell Cycle 21:19, pages 2027-2037.
Read now
Xiaofeng Wu, Jing Zhu, Wei Liu, Meng Jin, Mengqing Xiong & Ke Hu. (2021) A Novel Prognostic and Predictive Signature for Lung Adenocarcinoma Derived from Combined Hypoxia and Infiltrating Immune Cell-Related Genes in TCGA Patients. International Journal of General Medicine 14, pages 10467-10481.
Read now
Kah Min Yap, Mahendran Sekar, Lay Jing Seow, Siew Hua Gan, Srinivasa Reddy Bonam, Nur Najihah Izzati Mat Rani, Pei Teng Lum, Vetriselvan Subramaniyan, Yuan Seng Wu, Neeraj Kumar Fuloria & Shivkanya Fuloria. (2021) Mangifera indica (Mango): A Promising Medicinal Plant for Breast Cancer Therapy and Understanding Its Potential Mechanisms of Action. Breast Cancer: Targets and Therapy 13, pages 471-503.
Read now
Sugumari Vallinayagam, Karthikeyan Rajendran & Vigneshkumar Sekar. (2021) Pro-apoptotic property of phytocompounds from Naringi crenulata in HER2+ breast cancer cells in vitro. Biotechnology & Biotechnological Equipment 35:1, pages 303-314.
Read now
Wanhua Zhang, Pu Kuang & Ting Liu. (2019) Prognostic significance of CDKN2A/B deletions in acute lymphoblastic leukaemia: a meta-analysis. Annals of Medicine 51:1, pages 28-40.
Read now

Articles from other publishers (84)

Muktashree Saha & Siddhartha Sankar Ghosh. (2023) Targeting tumor microenvironment of metastatic triple negative breast cancer cells via exosomes derived from non-invasive breast cancer cells for multi-drug resistance inhibition and enhancing drug susceptibility. Journal of Drug Delivery Science and Technology 89, pages 105028.
Crossref
Huan Chen, Guoping Xie, Qunying Luo, Yisha Yang & Siheng Hu. (2023) Regulatory miRNAs, circRNAs and lncRNAs in cell cycle progression of breast cancer. Functional & Integrative Genomics 23:3.
Crossref
Vishnu Kumarasamy, Zhe Gao, Bosheng Zhao, Baishan Jiang, Seth M. Rubin, Kevin Burgess, Agnieszka K. Witkiewicz & Erik S. Knudsen. (2023) PROTAC-mediated CDK degradation differentially impacts cancer cell cycles due to heterogeneity in kinase dependencies. British Journal of Cancer.
Crossref
Maxim E. Astashev, Dmitriy A. Serov & Sergey V. Gudkov. (2023) Application of Spectral Methods of Analysis for Description of Ultradian Biorhythms at the Levels of Physiological Systems, Cells and Molecules (Review). Mathematics 11:15, pages 3307.
Crossref
Ali Ahmadizad Firouzjaei, Kazem Sharifi, Majid Khazaei, Samira Mohammadi‐Yeganeh & Seyed Hamid Aghaee‐Bakhtiari. (2023) Screening and introduction of key cell cycle microRNAs deregulated in colorectal cancer by integrated bioinformatics analysis . Chemical Biology & Drug Design 102:1, pages 137-152.
Crossref
Sarah A. Badawy, Ahmed R. Hassan, Rawah H. Elkousy, Salwa A. Abu El wafa & Abd-El salam I. Mohammad. (2023) New cyclic glycolipids from Silene succulenta promote in vitro MCF-7 breast carcinoma cell apoptosis by cell cycle arrest and in silico mitotic Mps1/TTK inhibition . RSC Advances 13:27, pages 18627-18638.
Crossref
Huixin Wu, William J. Van Der Pol, Laura G. Dubois, Casey D. Morrow & Trygve O. Tollefsbol. (2023) Dietary Supplementation of Inulin Contributes to the Prevention of Estrogen Receptor-Negative Mammary Cancer by Alteration of Gut Microbial Communities and Epigenetic Regulations. International Journal of Molecular Sciences 24:10, pages 9015.
Crossref
Monalisa Parija, Amit K. Adhya & Sandip K. Mishra. (2023) G-protein-coupled receptor 141 mediates breast cancer proliferation and metastasis by regulating oncogenic mediators and the p-mTOR/p53 axis. Oncotarget 14:1, pages 466-480.
Crossref
Bashdar Mahmud Hussen, Mohammad Taheri, Kimia Behzad Moghadam, Mahdi Gholipour, Solat Eslami, Amir Nicknam, Hazha Jamal Hidayat, Soudeh Ghafouri-Fard & Asghar Ashrafi Hafez. (2023) Expression analysis of cell cycle related lncRNAs in breast cancer tissues. Pathology - Research and Practice 245, pages 154453.
Crossref
Eunji Kang, Hong-Kyu Kim, Han-Byoel Lee & Wonshik Han. (2023) Never in mitosis gene A-related kinase-8 promotes proliferation, migration, invasion, and stemness of breast cancer cells via β-catenin signalling activation. Scientific Reports 13:1.
Crossref
Mohsen Karami Fath, Zahra Moayedi Banan, Reza Barati, Omid Mohammadrezakhani, Aliasghar Ghaderi, Ali Hatami, Shamim Ghiabi, Nazanin Zeidi, Katayoon Asgari, Zahra Payandeh & Ghasem Barati. (2023) Recent advancements to engineer mesenchymal stem cells and their extracellular vesicles for targeting and destroying tumors. Progress in Biophysics and Molecular Biology 178, pages 1-16.
Crossref
Arif Ahmad Rather & Manzoor Ahmad Chachoo. (2023) Robust correlation estimation and UMAP assisted topological analysis of omics data for disease subtyping. Computers in Biology and Medicine 155, pages 106640.
Crossref
Lin Wang, Yu Sun, Jingkai Wang, Yanli Xue, Yin Sun, Qiaohua Qin, Yixiang Sun, Dongmei Zhao & Maosheng Cheng. (2022) Design, synthesis, and biological evaluation of a potent PLK4 inhibitor WY29 with 1 H ‐pyrazolo[3,4‐ d ]pyrimidine scaffold . Archiv der Pharmazie 356:3.
Crossref
Md. Ariful Islam, Md. Bayazid Hossen, Md. Abu Horaira, Md. Alim Hossen, Md. Kaderi Kibria, Md. Selim Reza, Khanis Farhana Tuly, Md. Omar Faruqe, Firoz Kabir, Rashidul Alam Mahumud & Md. Nurul Haque Mollah. (2023) Exploring Core Genes by Comparative Transcriptomics Analysis for Early Diagnosis, Prognosis, and Therapies of Colorectal Cancer. Cancers 15:5, pages 1369.
Crossref
Pei-Hsuan Hsieh, Yamuna Phal, Kannanganattu V. Prasanth & Rohit Bhargava. (2022) Cell Phase Identification in a Three-Dimensional Engineered Tumor Model by Infrared Spectroscopic Imaging. Analytical Chemistry 95:6, pages 3349-3357.
Crossref
Liliana-Roxana Balahura (Stămat), Sorina Dinescu & Marieta Costache. (2023) Regulation of Inflammasome by microRNAs in Triple-Negative Breast Cancer: New Opportunities for Therapy. International Journal of Molecular Sciences 24:4, pages 3245.
Crossref
Aadil Javed, Mahdieh Yarmohammadi, Kemal Sami Korkmaz & Teresa Rubio-Tomás. (2023) The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer. International Journal of Molecular Sciences 24:3, pages 2848.
Crossref
Kankan Zhao, Yuan Zheng, Wenliang Lu & Bo Chen. (2023) Identification of ubiquitination-related gene classification and a novel ubiquitination-related gene signature for patients with triple-negative breast cancer. Frontiers in Genetics 13.
Crossref
Priscilla A. Furth, Weisheng Wang, Keunsoo Kang, Brendan L. Rooney, Grace Keegan, Vinona Muralidaran, Xiaojun Zou & Jodi A. Flaws. (2023) Esr1 but Not CYP19A1 Overexpression in Mammary Epithelial Cells during Reproductive Senescence Induces Pregnancy-Like Proliferative Mammary Disease Responsive to Anti-Hormonals. The American Journal of Pathology 193:1, pages 84-102.
Crossref
Homa Fatma & Hifzur R. Siddique. 2023. Regulation of Downstream Targets. Regulation of Downstream Targets 115 145 .
Manzoor Ahmad Mir, Shazia Sofi & Pir M. Ishfaq. 2023. Therapeutic potential of Cell Cycle Kinases in Breast Cancer. Therapeutic potential of Cell Cycle Kinases in Breast Cancer 175 194 .
Manzoor Ahmad Mir & Abrar Yousuf Mir. 2023. Therapeutic potential of Cell Cycle Kinases in Breast Cancer. Therapeutic potential of Cell Cycle Kinases in Breast Cancer 149 174 .
Manzoor Ahmad Mir, Sameer Ullah Khan & Shariqa Aisha. 2023. Therapeutic potential of Cell Cycle Kinases in Breast Cancer. Therapeutic potential of Cell Cycle Kinases in Breast Cancer 103 131 .
Manzoor Ahmad Mir & Asma Jan. 2023. Therapeutic potential of Cell Cycle Kinases in Breast Cancer. Therapeutic potential of Cell Cycle Kinases in Breast Cancer 53 82 .
Manzoor Ahmad Mir & Ulfat Jan. 2023. Therapeutic potential of Cell Cycle Kinases in Breast Cancer. Therapeutic potential of Cell Cycle Kinases in Breast Cancer 211 232 .
Pia Giovannelli, Gabriella Castoria & Antimo Migliaccio. 2023.
Shade’ A. Ahmed, Patricia Mendonca, Rashid Elhag & Karam F. A. Soliman. (2022) Anticancer Effects of Fucoxanthin through Cell Cycle Arrest, Apoptosis Induction, Angiogenesis Inhibition, and Autophagy Modulation. International Journal of Molecular Sciences 23:24, pages 16091.
Crossref
Logan Slade, Dipsikha Biswas, Petra C. Kienesberger & Thomas Pulinilkunnil. (2022) Loss of transcription factor EB dysregulates the G1/S transition and DNA replication in mammary epithelial cells. Journal of Biological Chemistry 298:12, pages 102692.
Crossref
Zhiming Hu, Caina Xu, Yonghao Liang, Taiyuan Liu, Huayu Tian & Yingchao Zhang. (2022) Multifunctional drug delivery nanoparticles based on MIL-100 (Fe) for photoacoustic imaging-guided synergistic chemodynamic/chemo/photothermal breast cancer therapy. Materials & Design 223, pages 111132.
Crossref
Fatemeh Sadoughi, Parisa Maleki Dana, Zatollah Asemi, Rana Shafabakhash, Sotoudeh Mohammadi, Zahra Heidar, Masoumeh Mirzamoradi, Niloufar Targhazeh & Hamed Mirzaei. (2022) Molecular and cellular mechanisms of melatonin in breast cancer. Biochimie 202, pages 26-33.
Crossref
Yuan Zheng, Wenliang Lu, Bo Chen & Kankan Zhao. (2022) Identification of a novel ubiquitination related gene signature for patients with breast cancer. Medicine 101:37, pages e30598.
Crossref
Antonella Di Sotto, Marco Gullì, Marco Minacori, Romina Mancinelli, Stefania Garzoli, Ester Percaccio, Alessio Incocciati, Donatella Romaniello, Gabriela Mazzanti, Margherita Eufemi & Silvia Di Giacomo. (2022) β-Caryophyllene Counteracts Chemoresistance Induced by Cigarette Smoke in Triple-Negative Breast Cancer MDA-MB-468 Cells. Biomedicines 10:9, pages 2257.
Crossref
Isabel Soria-Bretones, Kelsie L. Thu, Jennifer SilvesterJennifer CruickshankSamah El GhamrasniWail Ba-alawi, Graham C. Fletcher, Reza Kiarash, Mitchell J. Elliott, Jordan J. Chalmers, Andrea C. EliaAlbert Cheng, April A. N. Rose, Mark R. Bray, Benjamin Haibe-KainsTak W. Mak & David W. Cescon. (2022) The spindle assembly checkpoint is a therapeutic vulnerability of CDK4/6 inhibitor–resistant ER + breast cancer with mitotic aberrations . Science Advances 8:36.
Crossref
Fatma Abo-Elghiet, Mona H. Ibrahim, Mahmoud A. El Hassab, Ammar Bader, Qasem M.A. Abdallah & Abeer Temraz. (2022) LC/MS analysis of Viscum cruciatum Sieber ex Boiss. extract with anti-proliferative activity against MCF-7 cell line via G0/G1 cell cycle arrest: An in-silico and in-vitro study. Journal of Ethnopharmacology 295, pages 115439.
Crossref
Yun-yun Zhang, Pan-pan Feng, Hong-fei Wang, Heng Zhang, Tao Liang, Xiao-shan Hao, Feng-ze Wang & Hong-rong Fei. (2022) Licochalcone B induces DNA damage, cell cycle arrest, apoptosis, and enhances TRAIL sensitivity in hepatocellular carcinoma cells. Chemico-Biological Interactions 365, pages 110076.
Crossref
Saeed Noorolyai, Elham Baghbani, Shima Rahmani, Mahdi Abdoli Shadbad, Nooshin Montazami, Farinaz Jigari-Asl, Aysan Fallah Vazirabad & Behzad Baradaran. (2022) hsa-miR-34a-5p potentiates cytarabine-mediated cell cycle arrest in MDA-MB-231 cells: a novel combination therapy. Pathology - Research and Practice 236, pages 154004.
Crossref
Fui Fui Lem, Bo Eng Cheong & Peik Lin Teoh. (2022) Ruellia tuberosa Ethyl Acetate Leaf Extract Induces Apoptosis and Cell Cycle Arrest in Human Breast Cancer Cell Line, MCF-7. Scientia Pharmaceutica 90:3, pages 44.
Crossref
Ru‐Lin Huang, Chuanqi Liu, Rao Fu, Yuxin Yan, Jing Yang, Xinggang Wang & Qingfeng Li. (2022) Downregulation of PLK4 expression induces apoptosis and G0 / G1‐phase cell cycle arrest in keloid fibroblasts . Cell Proliferation 55:7.
Crossref
Vishnu Kumarasamy, Ram Nambiar, Jianxin Wang, Hanna Rosenheck, Agnieszka K. Witkiewicz & Erik S. Knudsen. (2022) RB loss determines selective resistance and novel vulnerabilities in ER-positive breast cancer models. Oncogene 41:27, pages 3524-3538.
Crossref
Nischal Koirala, Nandini Dey, Jennifer Aske & Pradip De. (2022) Targeting Cell Cycle Progression in HER2+ Breast Cancer: An Emerging Treatment Opportunity. International Journal of Molecular Sciences 23:12, pages 6547.
Crossref
Xihui Chen, Shiwen Wang, Li Zhang, Shuying Yuan, Tong Xu, Feng Zhu, Yanmei Zhang & Lijun Jia. (2022) Celastrol Inhibited Human Esophageal Cancer by Activating DR5-Dependent Extrinsic and Noxa/Bim-Dependent Intrinsic Apoptosis. Frontiers in Pharmacology 13.
Crossref
Pietro Gentile. (2022) Breast Cancer Therapy: The Potential Role of Mesenchymal Stem Cells in Translational Biomedical Research. Biomedicines 10:5, pages 1179.
Crossref
Michele Tumminello, Giorgio Bertolazzi, Gianluca Sottile, Nicolina Sciaraffa, Walter Arancio & Claudia Coronnello. (2022) A multivariate statistical test for differential expression analysis. Scientific Reports 12:1.
Crossref
Shazia Sofi, Umar Mehraj, Hina Qayoom, Shariqa Aisha, Syed Mohammad Basheeruddin Asdaq, Abdullah Almilaibary & Manzoor A. Mir. (2022) Cyclin-dependent kinases in breast cancer: expression pattern and therapeutic implications. Medical Oncology 39:6.
Crossref
Yingchu Gu, Runze Zhang, Bin Jiang, Xin Xu, Jun Jie Guan, Xing Jie Jiang, Yuan Zhou, You Lang Zhou & Xiangdong Chen. (2021) Repair of Spinal Cord Injury by Inhibition of PLK4 Expression Through Local Delivery of siRNA-Loaded Nanoparticles. Journal of Molecular Neuroscience 72:3, pages 544-554.
Crossref
Faten Zahran Mohammed, Youstina William Rizzk, Ibrahim Mohey El‐Deen, Emad M. Gad, Mohammed El Behery & Ahmed R. E. Mahdy. (2022) Discovery of 2‐Amino‐4H‐1, 3, 4‐thiadiazine‐5(6H)‐one Derivatives and Their In Vitro Antitumor Investigation. ChemistrySelect 7:7.
Crossref
Danxian Jiang, Yin Li, Jinxin Cao, Lianghe Sheng, Xinhai Zhu & Meng Xu. (2022) Cell Division Cycle-Associated Genes Are Potential Immune Regulators in Nasopharyngeal Carcinoma. Frontiers in Oncology 12.
Crossref
Luke R. Odell, Ngoc Chau, Cecilia C. Russell, Kelly A. Young, Jayne Gilbert, Phillip J. Robinson, Jennette A. Sakoff & Adam McCluskey. (2021) Pyrimidyn‐Based Dynamin Inhibitors as Novel Cytotoxic Agents. ChemMedChem 17:1.
Crossref
Yang Luo, Yue Zhang, Yu‐Xin Wu, Han‐Bing Li, Di Shen & Yi‐Qun Che. (2021) Development of a novel five‐lncRNA prognostic signature for predicting overall survival in elderly patients with breast cancer. Journal of Clinical Laboratory Analysis 36:1.
Crossref
Inyoung Kim, Sangseon Lee, Youngkuk Kim, Hugh Namkoong & Sun Kim. (2021) A probabilistic model for pathway-guided gene set selection. A probabilistic model for pathway-guided gene set selection.
Dhania Novitasari, Riris Istighfari Jenie, Jun-ya Kato & Edy Meiyanto. (2021) The integrative bioinformatic analysis deciphers the predicted molecular target gene and pathway from curcumin derivative CCA-1.1 against triple-negative breast cancer (TNBC). Journal of the Egyptian National Cancer Institute 33:1.
Crossref
Jinling Liao, Qiong Song, Jie Li, Kechen Du, Yang Chen, Chunlin Zou & Zengnan Mo. (2021) Carcinogenic effect of adenylosuccinate lyase (ADSL) in prostate cancer development and progression through the cell cycle pathway. Cancer Cell International 21:1.
Crossref
Cui Zhao, Jian Liu, Haomiao Zhou, Xin Qian, Hui Sun, Xuewen Chen, Miaosen Zheng, Tingting Bian, Lei Liu, Yifei Liu & Jianguo Zhang. (2021) NEIL3 may act as a potential prognostic biomarker for lung adenocarcinoma. Cancer Cell International 21:1.
Crossref
Yanting Wang, Xianyue Ren, Weiyu Li, Ruoyan Cao, Suyang Liu, Laibo Jiang, Bin Cheng & Juan Xia. (2021) SPDEF suppresses head and neck squamous cell carcinoma progression by transcriptionally activating NR4A1. International Journal of Oral Science 13:1.
Crossref
Feng Li, Chun-Sheng Liu, Ping Wu, An-Sheng Ling, Qi PanXiao-Ning Li. (2021) CCT4 suppression inhibits tumor growth in hepatocellular carcinoma by interacting with Cdc20. Chinese Medical Journal 134:22, pages 2721-2729.
Crossref
Ji Hye Jeong, Jae-Ha Ryu & Hwa Jin Lee. (2021) In Vitro Inhibition of Piper nigrum and Piperine on Growth, Migration, and Invasion of PANC-1 Human Pancreatic Cancer Cells . Natural Product Communications 16:11, pages 1934578X2110576.
Crossref
Gangga Anuraga, Wei-Jan Wang, Nam Nhut Phan, Nu Thuy An Ton, Hoang Dang Khoa Ta, Fidelia Berenice Prayugo, Do Thi Minh Xuan, Su-Chi Ku, Yung-Fu Wu, Vivin Andriani, Muhammad Athoillah, Kuen-Haur Lee & Chih-Yang Wang. (2021) Potential Prognostic Biomarkers of NIMA (Never in Mitosis, Gene A)-Related Kinase (NEK) Family Members in Breast Cancer. Journal of Personalized Medicine 11:11, pages 1089.
Crossref
Ana CarolinaSilveira Rabelo, Jéssica Borghesi, Ana Claudia O. Carreira, Rafael Gonçalves Hayashi, Fernanda Bessa, Rodrigo da Silva Nunes Barreto, Romário Pereira da Costa, Antônio José Cantanhede Filho, Fernando José Costa Carneiro & Maria Angélica Miglino. (2021) Calotropis procera (Aiton) Dryand (Apocynaceae) as an anti-cancer agent against canine mammary tumor and osteosarcoma cells. Research in Veterinary Science 138, pages 79-89.
Crossref
Ziyi Yang, Haiyan Sun, Wenlong Ma, Kai Wu, Guoyu Peng, Tong Ou & Song Wu. (2021) Down‐regulation of Polo‐like kinase 4 (PLK4) induces G1 arrest via activation of the p38/p53/p21 signaling pathway in bladder cancer. FEBS Open Bio 11:9, pages 2631-2646.
Crossref
E. Amiri Souri, A. Chenoweth, A. Cheung, S. N. Karagiannis & S. Tsoka. (2021) Cancer Grade Model: a multi-gene machine learning-based risk classification for improving prognosis in breast cancer. British Journal of Cancer 125:5, pages 748-758.
Crossref
Armen Parsyan, Jennifer Cruickshank, Kelsey Hodgson, Drew Wakeham, Sierra Pellizzari, Vasudeva Bhat & David W. Cescon. (2021) Anticancer effects of radiation therapy combined with Polo-Like Kinase 4 (PLK4) inhibitor CFI-400945 in triple negative breast cancer. The Breast 58, pages 6-9.
Crossref
Reyhaneh Farghadani & Rakesh Naidu. (2021) Curcumin: Modulator of Key Molecular Signaling Pathways in Hormone-Independent Breast Cancer. Cancers 13:14, pages 3427.
Crossref
Eliane Pedra Dias, Nathália Silva Carlos Oliveira, Amanda Oliveira Serra-Campos, Anna Karoline Fausto da Silva, Licínio Esmeraldo da Silva & Karin Soares Cunha. (2021) A novel evaluation method for Ki-67 immunostaining in paraffin-embedded tissues. Virchows Archiv 479:1, pages 121-131.
Crossref
Xingte Chen, Lei Wang, Liang Hong, Zhixiong Su, Xiaohong Zhong, Han Zhou, Xueqing Zhang, Junxin Wu & Lingdong Shao. (2021) Identification of Aging-Related Genes Associated With Clinical and Prognostic Features of Hepatocellular Carcinoma. Frontiers in Genetics 12.
Crossref
Chen Chen, Dan Gao, Jinlong Huo, Rui Qu, Youming Guo, Xiaochi Hu & Libo Luo. (2021) Multiomics analysis reveals CT83 is the most specific gene for triple negative breast cancer and its hypomethylation is oncogenic in breast cancer. Scientific Reports 11:1.
Crossref
Hope S Rugo, Anja Haltner, Lin Zhan, Anh Tran, Eustratios Bananis, Becky Hooper, Debanjali Mitra & Chris Cameron. (2021) Matching-adjusted indirect comparison of palbociclib versus ribociclib and abemaciclib in hormone receptor-positive/HER2-negative advanced breast cancer. Journal of Comparative Effectiveness Research 10:6, pages 457-467.
Crossref
Anna-Lena Volckmar, Petros Christopoulos, Martina Kirchner, Michael Allgäuer, Olaf Neumann, Jan Budczies, Eugen Rempel, Peter Horak, Julia Glade, Hannah Goldschmid, Huriye Seker-Cin, Regine Brandt, Mark Kriegsmann, Jonas Leichsenring, Hauke Winter, Martin Faehling, Jürgen R. Fischer, Claus Peter Heußel, Felix Herth, Tilman Brummer, Stefan Fröhling, Peter Schirmacher, Michael Thomas, Volker Endris, Roland Penzel, Daniel Kazdal, Tilmann Bochtler & Albrecht Stenzinger. (2021) Targeting rare and non-canonical driver variants in NSCLC – An uncharted clinical field. Lung Cancer 154, pages 131-141.
Crossref
Suryendu Saha, Samya Dey & Somsubhra Nath. (2021) Steroid Hormone Receptors: Links With Cell Cycle Machinery and Breast Cancer Progression. Frontiers in Oncology 11.
Crossref
Xiaoyang Zhang, Cheng Wei, Hao Liang & Lei Han. (2021) Polo-Like Kinase 4’s Critical Role in Cancer Development and Strategies for Plk4-Targeted Therapy. Frontiers in Oncology 11.
Crossref
Nahla E. EL-Ashmawy, Enas A. EL-Zamarany, Naglaa F. Khedr, Hend M. Selim & Eman G. Khedr. (2021) Inhibition of PKC/MEK pathway suppresses β1-integrin and mitigates breast cancer cells proliferation. Toxicology Reports 8, pages 1530-1537.
Crossref
Wenbao Lu, Meicen Zhou, Bing Wang, Xueting Liu & Bingwei Li. (2020) Roquin1 inhibits the proliferation of breast cancer cells by inducing G1/S cell cycle arrest via selectively destabilizing the mRNAs of cell cycle–promoting genes. Journal of Experimental & Clinical Cancer Research 39:1.
Crossref
Leonardo Bruno Federico, Guilherme Martins Silva, Amanda de Fraga Dias, Fabrício Figueiró, Ana Maria Oliveira Battastini, Cleydson Breno Rodrigues dos Santos, Luciano T. Costa, Joaquín Maria Carmpos Rosa & Carlos Henrique Tomich de Paula da Silva. (2020) Identification of novel αβ-tubulin modulators with antiproliferative activity directed to cancer therapy using ligand and structure-based virtual screening. International Journal of Biological Macromolecules 165, pages 3040-3050.
Crossref
Adewale Oluwaseun Fadaka, Nicole Remaliah Samantha Sibuyi, Abram Madimabe Madiehe & Mervin Meyer. (2020) MicroRNA-based regulation of Aurora A kinase in breast cancer. Oncotarget 11:46, pages 4306-4324.
Crossref
Zhuoyu Gu, Liping Wang, Xiaohan Yao, Qian Long, Kaping Lee, Jieyao Li, Dongli Yue, Shuangning Yang, Yanfen Liu, Na Li & Yixin Li. (2020) ClC-3/SGK1 regulatory axis enhances the olaparib-induced antitumor effect in human stomach adenocarcinoma. Cell Death & Disease 11:10.
Crossref
Abdus Samad, Farhana Haque, Zulkar Nain, Rahat Alam, Md Abdullah Al Noman, Mohammad Habibur Rahman Molla, Md Saddam Hossen, Md Raquibul Islam, Md Iqbal Khan & Foysal Ahammad. (2020) Computational assessment of MCM2 transcriptional expression and identification of the prognostic biomarker for human breast cancer. Heliyon 6:10, pages e05087.
Crossref
Giuseppina Augimeri, Cinzia Giordano, Luca Gelsomino, Pierluigi Plastina, Ines Barone, Stefania Catalano, Sebastiano Andò & Daniela Bonofiglio. (2020) The Role of PPARγ Ligands in Breast Cancer: From Basic Research to Clinical Studies. Cancers 12:9, pages 2623.
Crossref
Yu Xiang, Bin Fang, Yilin Liu, Siqi Yan, Dedong Cao, Huiling Mei, Qiuguo Wang, Yu Hu & Tao Guo. (2020) SR18292 exerts potent antitumor effects in multiple myeloma via inhibition of oxidative phosphorylation. Life Sciences 256, pages 117971.
Crossref
Xinrong Li, Junquan Zhu & Jian Qiu. (2020) Identification of Potential Prognostic Biomarkers for Breast Cancer Based on lncRNA-TF-Associated ceRNA Network and Functional Module. BioMed Research International 2020, pages 1-13.
Crossref
Yuu Kimata, Maïté Leturcq & Rajaguru Aradhya. (2020) Emerging roles of metazoan cell cycle regulators as coordinators of the cell cycle and differentiation. FEBS Letters 594:13, pages 2061-2083.
Crossref
Lei Ding, Jiaqi Cao, Wen Lin, Hongjian Chen, Xianhui Xiong, Hongshun Ao, Min Yu, Jie Lin & Qinghua Cui. (2020) The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer. International Journal of Molecular Sciences 21:6, pages 1960.
Crossref
Barnali Deb, Pratyay Sengupta, Janani Sambath & Prashant Kumar. (2020) Bioinformatics Analysis of Global Proteomic and Phosphoproteomic Data Sets Revealed Activation of NEK2 and AURKA in Cancers. Biomolecules 10:2, pages 237.
Crossref
Andrea Necchi, Gennady Bratslavsky, Oleg Shapiro, Julia A. Elvin, Jo-Anne Vergilio, Jonathan K. Killian, Nhu Ngo, Shakti Ramkissoon, Eric Severson, Amanda C. Hemmerich, Siraj M. Ali, Jon H. Chung, Prasanth Reddy, Vincent A. Miller, Alexa B. Schrock, Laurie M. Gay, Jeffrey S. Ross & Joseph M. Jacob. (2019) Genomic Features of Metastatic Testicular Sex Cord Stromal Tumors. European Urology Focus 5:5, pages 748-755.
Crossref
Sari Haryanti, Ika Yanti M. Sholikhah & Yuli Widiyastuti. Cytotoxic and anti-migratory effects of Brucea javanica fruits extract on 4T1 breast cancer cells. Cytotoxic and anti-migratory effects of Brucea javanica fruits extract on 4T1 breast cancer cells.
Mayang Fati Kusuma & Fajar Adi-Kusumo. A mathematical modelling for estradiol influence on DNA damage response and G1/S transition phase regulations in early stage of breast cancer. A mathematical modelling for estradiol influence on DNA damage response and G1/S transition phase regulations in early stage of breast cancer.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.